Immuno. Sys

Immunodiagnostic Systems (IDH)

Buy
Sell
Company name:Immuno. Sys
EPIC:IDHTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00B01YZ052
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.idsltd.com/Description:ORD 2P
Industry Sector:HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Offer Open High Low Volume
 175.00 uk.advfn.com/p.php?gfx=/gb/dot 0.0 [0.00] 170.00 180.00 170.00 175.00 170.00 558
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 50.37 28.78 -0.02 4.20 1.70 41.67 0.97 275.00 - 165.00

Immunodiagnostic Systems Key Figures

(at previous day's close)
Market Cap.50.37m
Shares In Issue28.78m
Prev. Close175.00
PE Ratio41.67 
Dividend Yield0.97%
EPS - basic4.20p
Dividend PS1.70p
Dividend Cover2.47 
Cash Flow PS8.74p
Return On Equity (ROE)2.16%
Operating Margin2.46%
PEG Factor-0.71 
EPS Growth Rate-58.82%
Dividends PS Growth Rate-57.50%
Net Debt-17.86m
Gross Gearing15.80%
Quick Assets40.35m
Net Working Capital41.47m
Intangibles / Fixed Assets58.44%
Turnover PS131.83p
Pre-Tax Profit PS3.25p
Retained Profit PS0.17p
Cash PS99.13p
Net Cash PS73.89p
Net Tangible Asset Value PS *159.39p
Net Asset Value PS197.58p
Spread10.00 (5.56%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Immunodiagnostic Systems Balance Sheet

LSE:IDH:Liabilities+EQLSE:IDH:Assets

Share Price Performance

Sample Period †HighLow
1 week180.00170.00
4 weeks180.00165.00
12 weeks195.50165.00
1 year275.00165.00

Share Price Chart (5 years)

Immunodiagnostic Systems Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week175.00--170.000.00175.00
4 weeks170.005.002.94165.000.01174.00
12 weeks182.50-7.50-4.11165.000.01180.66
26 weeks216.00-41.00-18.98165.000.01187.26
1 year223.00-48.00-21.52165.000.01211.12
3 years177.50-2.50-1.41112.500.02199.54
5 years506.50-331.50-65.45112.500.03279.35
† periods calculated are whole weeks rather than calendar months

Immunodiagnostic Systems Key Management Ratios

Immunodiagnostic Systems Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio6.78 
PE Ratio41.67 
Tobin's Q Ratio 0.74 
Tobin's Q Ratio (excl. intangibles)0.88 
Dividend Yield0.97%
Market-to-Book Ratio0.89 
Price-to-Pre-Tax Profit PS53.87 
Price-to-Retained Profit PS1,007.44 
Price-to-Cash Flow PS20.02 
Price-to-Sales PS1.33 
Price-to-Net Tangible Asset Value PS1.10 
Price-to-Cash PS1.77 
Net Working Capital PS144.06 
Price Pct to Working Capital PS1.21%
Earnings Yield2.40%
Average PE34.68 
Years in average4 
PE to PE average120.14%

Immunodiagnostic Systems Financial Ratios

(Leverage Ratios)
Debt Ratio5.65%
Debt-to-Equity Ratio0.06 
Debt-to-Equity Ratio (excl. Intgbl)0.07 
Debt-to-Equity Market Value0.07 
Net Gearing-26.45%
Net Gearing (excl. Intangibles)-31.59%
Gross Gearing15.80%
Gross Gearing (excl. Intangibles)18.87%
Gearing Under 1 Year10.75%
Gearing Under 1 Year (excl. Intgbl)12.85%
Assets/Equity1.19 
Cash/Equity50.17 
(Liquidity Ratios)
Net Working Capital to Total Assets61.39%
Current Ratio6.71 
Quick Ratio (Acid Test)5.56 
Liquidity Ratio3.93 
Cash & Equiv/Current Assets58.55%
(Solvency Ratios)
Enterprise Value25.24m
CFO/Sales0.07 
CFO/Attributable Profit2.05 
CFO/Assets0.04 
CFO/Debt0.24 
Total Debt/Equity Market Value0.21 
Total Debt/Sales0.28 
Total Debt/Pre-Tax Profit11.41 
Total Debt10.67m
Total Debt/Net Current Assets0.26%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
-0.01800.1828

Immunodiagnostic Systems Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)1.55%
Return On Assets (ROA)1.80%
Net Profit Margin3.23%
Assets Turnover0.56 
Return On Equity (ROE)2.16%
Return On Investment (ROI)2.03%
Dividend Payout Ratio40.48%
Plowback Ratio59.52%
Growth from Plowback Ratio1.29%
Net Income Of Revenues0.13%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.67 
Fixed Assets Turnover1.99 
Current Assets Turnover0.77 
Net Working Capital Turnover 
Inventory Turnover4.76 
(Other Operating Ratios)
Total Assets-to-Sales1.80 
Debtors-to-Sales29.25%
Debt Collection Period106.76Days

Immunodiagnostic Systems Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
20 Jun 2018FinalGBX1.7031/03/201731/03/201819/07/201820/07/201817/08/20181.70
21 Jun 2017FinalGBX4.0031/03/201631/03/201720/07/201721/07/201718/08/20174.00
22 Jun 2016FinalGBX1.2031/03/201531/03/201621/07/201622/07/201619/08/20161.20
23 Jun 2015FinalGBX3.0031/03/201431/03/201523/07/201524/07/201521/08/20153.00
24 Jun 2014FinalGBX8.5031/03/201331/03/201423/07/201425/07/201422/08/20148.50
17 Jun 2013FinalGBX3.0031/03/201231/03/201324/07/201326/07/201323/08/20133.00
25 Jun 2012FinalGBX2.7531/03/201131/03/201205/09/201207/09/201228/09/20122.75
27 Jun 2011FinalGBX2.5031/03/201031/03/201131/08/201102/09/201129/09/20112.50
12 Jul 2010FinalGBX2.0031/03/200931/03/201018/08/201020/08/201015/09/20102.00
22 Jun 2009FinalGBX1.6531/03/200831/03/200922/07/200924/07/200921/08/20091.65
16 Jul 2008FinalGBX1.5031/03/200731/03/200820/08/200822/08/200812/09/20081.50
16 Jul 2007FinalGBX1.2531/03/200631/03/200722/08/200724/08/200726/09/20071.25
05 Jul 2006FinalGBX1.0031/03/200531/03/200623/08/200625/08/200625/09/20061.00

Immunodiagnostic Systems Fundamentals
 31 Mar 2015 (GBP)31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)
turnover45.36100.00%38.31100.00%40.04100.00%37.95100.00%m
pre tax profit4.058.93%-37.02-96.65%1.192.97%0.942.46%m
attributable profit2.355.18%-32.17-83.98%3.017.52%1.233.23%m
retained profit-0.13-0.28%-33.05-86.27%2.666.63%0.050.13%m
eps - basic (p)8.10 -109.70 10.20 4.20 
eps - diluted (p)8.00 -109.70 10.20 4.20 
dividends per share3.00 1.20 4.00 1.70 

Immunodiagnostic Systems Balance Sheet

 31 Mar 2015 (GBP)31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)
LSE:IDH:Liabilities+EQLSE:IDH:AssetsLSE:IDH:Liabilities+EQLSE:IDH:AssetsLSE:IDH:Liabilities+EQLSE:IDH:AssetsLSE:IDH:Liabilities+EQLSE:IDH:Assets
 31 Mar 2015 (GBP)31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)
ASSETS
fixed assets fixed assets10.2610.57%9.6315.45%8.5112.37%7.4711.06%m
intangibles intangibles45.9047.27%9.2114.78%10.4515.20%10.9916.28%m
fixed investments fixed investments0.270.28%0.290.47%0.330.48%0.350.52%m
current assets - other current assets - other--%--%--%--%m
stocks stocks6.817.01%7.5112.05%7.5711.02%8.3812.40%m
debtors debtors10.1310.43%9.1414.67%10.3815.10%11.8217.50%m
cash & securities cash & securities23.7324.44%26.5542.60%31.5045.82%28.5342.25%m
TOTAL97.10100%62.34100%68.74100%67.54100%m
LIABILITIES
creditors - short creditors - short7.197.41%6.5510.51%8.2211.96%7.2610.75%m
creditors - long creditors - long9.509.78%4.196.72%3.785.51%3.415.04%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL16.6917.19%10.7417.23%12.0017.46%10.6715.80%m
EQUITY
ord cap, reserves ord cap, reserves80.4182.81%51.6082.77%56.7382.54%56.8784.20%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL80.4182.81%51.6082.77%56.7382.54%56.8784.20%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Immunodiagnostic Systems Cash Flow Statement

31 Mar 2015 (GBP)31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)
Operating CF9.478.198.442.52m
Pre-Financing CF0.863.364.81-1.35m
Retained CF-1.752.384.27-2.76m

Immunodiagnostic Systems Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Oriel Securities LimitedMarket Maker(MMF)Broker/DealerORELORSNGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
IDH
Immunodiag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190423 14:18:45